Ting Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ting Cheng has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Artiom Skripka
Department of Chemistry, Oregon State University
3 shared publications - Fiorenzo Vetrone
Université du Québec
3 shared publications A. Morinvil
Institute National de la Recherche Scientifique, Centre Énergie Matériaux Télécommunication, Université du Québec, 1650 Boul. Lionel-Boulet, Varennes, Québec J3X 1S2, Canada.
1 shared publicationAlex Y. Chang
Department of Oncology
1 shared publication- Federico Rosei
University of Trieste Via Giorgeri 1
1 shared publication Kishore Kumar Bhakoo
Singapore Bioimaging Consortium (SBIC), Agency for Science, Technology and Research (A*STAR), Singapore
1 shared publication
Latest Publications
- Open Access
- 1 June 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 11 (26) , 6653-6661
One-pot synthesis of theranostic nanocapsules with lanthanide doped nanoparticles
We report a one-pot synthesis strategy for a new theranostic nanoplatform by simultaneously encapsulating Er3+, Yb3+ doped NaGdF4 upconverting nanoparticles (UCNPs) and photosensitizer zinc phthalocyanine (ZnPc) into polymeric micelle/silica nanocapsules. This approach consists of interfacial templating condensation, using triblock copolymers, namely ethylene oxide)106(propylene oxide)70(ethylene oxide)106 (PEO-PPO-PEO), as the templating and protecting agent. The encapsulation follows a straightforward microemulsion mechanism in an aqueous environment of a near neutral pH. To prevent the interaction between the hydrophobic OA ligands of UCNPs and the silanol groups of hydrated tetramethoxysilane (TMOS), we adjusted the addition sequence of TMOS. It allowed first to encapsulate UCNPs in PEO-PPO-PEO micelles, and then grow the silica shell within the micellar PPO core and PEO corona interface. The silica shell is incorporated for its chemical and mechanical stability, while the PEO corona confers additional steric balance to the nanocapsule. Using this strategy we successfully co-encapsulated UCNPs and ZnPc in one-pot, and minimized the distance between the two payloads to facilitate the energy transfer from UCNPs to ZnPc, as compared to conventional PS loading in the mesoporous silica coating. The integrated nanocapsule has an average hydrodynamic size of 85 nm with a low polydispersity index of 0.1, and demonstrates excellent colloidal stability, biocompatibility, as well as enhanced negative contrast for T2-weighted imaging and photodynamic therapy. The latter is obtained through indirect excitation of co-encapsulated ZnPc by UCNPs, resulting in singlet oxygen generation and in vitro eradication of BT474 breast cancer cells. Overall, the presented one-pot approach shines light on the co-encapsulation of OA capped inorganic UCNPs with hydrophobic photosensitizers, constituting an important step forward in the surface engineering of UCNPs, as well as upconversion based photodynamic therapy delivery systems.
- 1 June 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 11 (26) , 6653-6661
Open AccessOne-pot synthesis of theranostic nanocapsules with lanthanide doped nanoparticles
We report a one-pot synthesis strategy for a new theranostic nanoplatform by simultaneously encapsulating Er3+, Yb3+ doped NaGdF4 upconverting nanoparticles (UCNPs) and photosensitizer zinc phthalocyanine (ZnPc) into polymeric micelle/silica nanocapsules. This approach consists of interfacial templating condensation, using triblock copolymers, namely ethylene oxide)106(propylene oxide)70(ethylene oxide)106 (PEO-PPO-PEO), as the templating and protecting agent. The encapsulation follows a straightforward microemulsion mechanism in an aqueous environment of a near neutral pH. To prevent the interaction between the hydrophobic OA ligands of UCNPs and the silanol groups of hydrated tetramethoxysilane (TMOS), we adjusted the addition sequence of TMOS. It allowed first to encapsulate UCNPs in PEO-PPO-PEO micelles, and then grow the silica shell within the micellar PPO core and PEO corona interface. The silica shell is incorporated for its chemical and mechanical stability, while the PEO corona confers additional steric balance to the nanocapsule. Using this strategy we successfully co-encapsulated UCNPs and ZnPc in one-pot, and minimized the distance between the two payloads to facilitate the energy transfer from UCNPs to ZnPc, as compared to conventional PS loading in the mesoporous silica coating. The integrated nanocapsule has an average hydrodynamic size of 85 nm with a low polydispersity index of 0.1, and demonstrates excellent colloidal stability, biocompatibility, as well as enhanced negative contrast for T2-weighted imaging and photodynamic therapy. The latter is obtained through indirect excitation of co-encapsulated ZnPc by UCNPs, resulting in singlet oxygen generation and in vitro eradication of BT474 breast cancer cells. Overall, the presented one-pot approach shines light on the co-encapsulation of OA capped inorganic UCNPs with hydrophobic photosensitizers, constituting an important step forward in the surface engineering of UCNPs, as well as upconversion based photodynamic therapy delivery systems.
- 27 May 2019
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 11 (23) , 11322-11330
Advancing neodymium single-band nanothermometry
Nd3+ doped LiLuF4 nanoparticles are explored as photoluminescent nanothermometers and imaging probes. Such host-dopant configuration permits to resolve the fine Stark structure of Nd3+ photoluminescence at 1050 nm, and to use it for subcutaneous temperature sensing.
- 27 May 2019
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 11 (23) , 11322-11330
Advancing neodymium single-band nanothermometry
Nd3+ doped LiLuF4 nanoparticles are explored as photoluminescent nanothermometers and imaging probes. Such host-dopant configuration permits to resolve the fine Stark structure of Nd3+ photoluminescence at 1050 nm, and to use it for subcutaneous temperature sensing.
- 14 September 2018
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 140 (40) , 12890-12899
Small and Bright Lithium-Based Upconverting Nanoparticles
In the context of light-mediated tumor treatment, the application of ultraviolet (UV) radiation can initiate drug release and photodynamic therapy. However, its limited penetration depth in tissues impedes the subcutaneous applicability of such radiation. On the contrary, near-infrared (NIR) light is not energetic enough to initiate secondary photochemical processes, but can pierce tissues at a significantly greater depth. Upconverting nanoparticles (UCNPs) unify the advantages of both extremes of the optical spectrum, they can be excited by NIR irradiation and emit UV light through the process of upconversion, effective NIR-to-UV generation being attained with UCNPs as large as 100 nm. However, in anticipation of biomedical applications, the size of UCNPs must be greatly minimized to favor their cellular internalization; yet straightforward size reduction negatively affects the NIR-to-UV upconversion efficiency. Herein, we propose a two-step strategy to obtain small yet bright lithium-based UCNPs. First, we synthesized UCNPs as small as 5 nm by controlling the relative amount of coordinating ligands, namely oleylamine (OM) and oleic acid (OA). Although these UCNPs were chemically unstable, particle coarsening via an annealing process in the presence of fresh OA yielded structurally stable and highly monodisperse sub-10 nm crystals. Second, we grew a shell with controlled thickness on these stabilized cores of UCNPs, improving the NIR-to-UV upconversion by orders of magnitude. Particularly in the case of LiYbF4:Tm3+/LiYF4 UCNPs, their NIR-to-UV upconversion surpassed the gold standard 90 nm-sized LiYF4:Tm3+, Yb3+ UCNPs. All in all, these UCNPs show great potential within the biomedical framework as they successfully combine the requirements of small size, deep tissue NIR penetration and bright UV emission.
- 14 September 2018
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 140 (40) , 12890-12899
Small and Bright Lithium-Based Upconverting Nanoparticles
In the context of light-mediated tumor treatment, the application of ultraviolet (UV) radiation can initiate drug release and photodynamic therapy. However, its limited penetration depth in tissues impedes the subcutaneous applicability of such radiation. On the contrary, near-infrared (NIR) light is not energetic enough to initiate secondary photochemical processes, but can pierce tissues at a significantly greater depth. Upconverting nanoparticles (UCNPs) unify the advantages of both extremes of the optical spectrum, they can be excited by NIR irradiation and emit UV light through the process of upconversion, effective NIR-to-UV generation being attained with UCNPs as large as 100 nm. However, in anticipation of biomedical applications, the size of UCNPs must be greatly minimized to favor their cellular internalization; yet straightforward size reduction negatively affects the NIR-to-UV upconversion efficiency. Herein, we propose a two-step strategy to obtain small yet bright lithium-based UCNPs. First, we synthesized UCNPs as small as 5 nm by controlling the relative amount of coordinating ligands, namely oleylamine (OM) and oleic acid (OA). Although these UCNPs were chemically unstable, particle coarsening via an annealing process in the presence of fresh OA yielded structurally stable and highly monodisperse sub-10 nm crystals. Second, we grew a shell with controlled thickness on these stabilized cores of UCNPs, improving the NIR-to-UV upconversion by orders of magnitude. Particularly in the case of LiYbF4:Tm3+/LiYF4 UCNPs, their NIR-to-UV upconversion surpassed the gold standard 90 nm-sized LiYF4:Tm3+, Yb3+ UCNPs. All in all, these UCNPs show great potential within the biomedical framework as they successfully combine the requirements of small size, deep tissue NIR penetration and bright UV emission.